Genus Plc Ownership
GENSF Stock | USD 20.90 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Genus |
Genus Pink Sheet Ownership Analysis
About 72.0% of the company shares are owned by institutional investors. The book value of Genus Plc was currently reported as 8.85. The company last dividend was issued on the 17th of November 2022. Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom. Genus Plc operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3500 people.The quote for Genus plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Genus plc call the company at 44 1256 347 100 or check out https://www.genusplc.com.Currently Active Assets on Macroaxis
Other Information on Investing in Genus Pink Sheet
Genus Plc financial ratios help investors to determine whether Genus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genus with respect to the benefits of owning Genus Plc security.